1. Home
  2. FONR vs PDSB Comparison

FONR vs PDSB Comparison

Compare FONR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FONR
  • PDSB
  • Stock Information
  • Founded
  • FONR 1978
  • PDSB 2005
  • Country
  • FONR United States
  • PDSB United States
  • Employees
  • FONR N/A
  • PDSB N/A
  • Industry
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • FONR Health Care
  • PDSB Health Care
  • Exchange
  • FONR Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • FONR 77.1M
  • PDSB 72.2M
  • IPO Year
  • FONR 1987
  • PDSB N/A
  • Fundamental
  • Price
  • FONR $16.08
  • PDSB $1.19
  • Analyst Decision
  • FONR
  • PDSB Strong Buy
  • Analyst Count
  • FONR 0
  • PDSB 2
  • Target Price
  • FONR N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • FONR 31.0K
  • PDSB 544.6K
  • Earning Date
  • FONR 05-15-2025
  • PDSB 08-12-2025
  • Dividend Yield
  • FONR N/A
  • PDSB N/A
  • EPS Growth
  • FONR N/A
  • PDSB N/A
  • EPS
  • FONR 1.28
  • PDSB N/A
  • Revenue
  • FONR $103,018,089.00
  • PDSB N/A
  • Revenue This Year
  • FONR N/A
  • PDSB N/A
  • Revenue Next Year
  • FONR N/A
  • PDSB N/A
  • P/E Ratio
  • FONR $12.47
  • PDSB N/A
  • Revenue Growth
  • FONR 0.29
  • PDSB N/A
  • 52 Week Low
  • FONR $12.00
  • PDSB $0.85
  • 52 Week High
  • FONR $18.68
  • PDSB $4.32
  • Technical
  • Relative Strength Index (RSI)
  • FONR 64.00
  • PDSB 39.96
  • Support Level
  • FONR $15.80
  • PDSB $1.02
  • Resistance Level
  • FONR $16.30
  • PDSB $1.28
  • Average True Range (ATR)
  • FONR 0.48
  • PDSB 0.11
  • MACD
  • FONR 0.02
  • PDSB -0.01
  • Stochastic Oscillator
  • FONR 73.61
  • PDSB 47.61

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: